Monitoring EGFR-Mutant Lung Cancers By Means of the Blood
Staging of the Brain: “Brainwashed” by Health Economics?
Semaphorins in Lung Cancer
Does Initial Staging or Tumor Histology Better Identify Asymptomatic Brain Metastases in Patients with Non–small Cell Lung Cancer?
Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group
Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer
Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer
Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial
Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer
Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience
EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer
A Single Lung Metastasis of Endometrioid Adenocarcinoma Synchronous with a Primary Bronchioloalveolar Carcinoma in the Same Lobe
A Review of First-Line Treatment for Small-cell Lung Cancer